-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the gradual improvement of living standards, people's demand for health services is very urge.
Therefore, in recent years, the state has also issued a series of favorable policies to further promote the development of the big health indust.
Prior to this, the state has issued relevant documents such as the "Healthy China Action (2019-2030)", centering on the two cores of disease prevention and health promotion, and proposed to carry out 15 major special actions to promote the treatment of diseases as the cent.
Health is the center of transformation, and efforts are made to make the masses not get sick and get sick less oft.
At present, with the support of many favorable policies and the continuous increase of capital, the scale of the big health industry will increase by an order of magnitu.
According to incomplete statistics, the market size of the big health industry has reached 7 trillion yuan in 202 Following this trend, the industry predicts that the market may exceed 8 trillion yuan by 202 It is worth noting that in recent years, many pharmaceutical companies are actively deploying the big health industry by increasing investment in R&D and cooperation, and are striving to get ahead of the tra.
For example, on May 6, China Resources Pharmaceutical, China Resources Sanjiu and Huali Pharmaceutical, a wholly-owned subsidiary of Huali Group, signed a strategic cooperation agreement and a share transfer agreeme.
According to the content of the agreement, the three parties will carry out comprehensive strategic cooperation in traditional Chinese medicine, big health industry and other related industries to jointly expand the global mark.
According to reports, the signing of the contract will play a positive role in promoting the cooperation parties to improve the industrial layout, improve the efficiency of resource allocation, and enhance competitivene.
On April 19, Huahai Pharmaceutical newly established Zhejiang Freeze-Drying Technology .
, L.
with a registered capital of 10 milli.
It is wholly-owned by Huahai Health Technology (Zhejiang) .
, L.
, a wholly-owned subsidiary of Huahai Pharmaceutic.
A technologically innovative company whose business scope includes technology development and promotion; food sales; health food (prepackaged) sales,e.
In addition, recently, the Imperial Palace Chain under the Imperial Palace also officially signed a strategic cooperation agreement with Gome Holdings' Oi.
It is reported that the Imperial Household Chain has cooperated with Oiyo this time to empower its health sector, and at the same time, it also links many businesses of Gome Group and the interconnection of the membership system, entering the fast lane of head resourc.
In general, under the influence of more and more perfect policies, the continuous improvement of China's economic growth and consumption capacity, and the continuous intensification of medical care caused by the aging of the population, the development of the big health industry in China will be accelerated, and the market will be expected in the futu.
It has become a new growth point of the national econo.
At the same time, a large number of enterprises will usher in more opportunities under this backgrou.
However, the scope of the big health industry is broad, including nutritional health food, medical health equipment, leisure health care services, e.
Industry insiders believe that if companies can break the single product model and provide healthy life solutions, they may create greater business opportuniti.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
Therefore, in recent years, the state has also issued a series of favorable policies to further promote the development of the big health indust.
Prior to this, the state has issued relevant documents such as the "Healthy China Action (2019-2030)", centering on the two cores of disease prevention and health promotion, and proposed to carry out 15 major special actions to promote the treatment of diseases as the cent.
Health is the center of transformation, and efforts are made to make the masses not get sick and get sick less oft.
At present, with the support of many favorable policies and the continuous increase of capital, the scale of the big health industry will increase by an order of magnitu.
According to incomplete statistics, the market size of the big health industry has reached 7 trillion yuan in 202 Following this trend, the industry predicts that the market may exceed 8 trillion yuan by 202 It is worth noting that in recent years, many pharmaceutical companies are actively deploying the big health industry by increasing investment in R&D and cooperation, and are striving to get ahead of the tra.
For example, on May 6, China Resources Pharmaceutical, China Resources Sanjiu and Huali Pharmaceutical, a wholly-owned subsidiary of Huali Group, signed a strategic cooperation agreement and a share transfer agreeme.
According to the content of the agreement, the three parties will carry out comprehensive strategic cooperation in traditional Chinese medicine, big health industry and other related industries to jointly expand the global mark.
According to reports, the signing of the contract will play a positive role in promoting the cooperation parties to improve the industrial layout, improve the efficiency of resource allocation, and enhance competitivene.
On April 19, Huahai Pharmaceutical newly established Zhejiang Freeze-Drying Technology .
, L.
with a registered capital of 10 milli.
It is wholly-owned by Huahai Health Technology (Zhejiang) .
, L.
, a wholly-owned subsidiary of Huahai Pharmaceutic.
A technologically innovative company whose business scope includes technology development and promotion; food sales; health food (prepackaged) sales,e.
In addition, recently, the Imperial Palace Chain under the Imperial Palace also officially signed a strategic cooperation agreement with Gome Holdings' Oi.
It is reported that the Imperial Household Chain has cooperated with Oiyo this time to empower its health sector, and at the same time, it also links many businesses of Gome Group and the interconnection of the membership system, entering the fast lane of head resourc.
In general, under the influence of more and more perfect policies, the continuous improvement of China's economic growth and consumption capacity, and the continuous intensification of medical care caused by the aging of the population, the development of the big health industry in China will be accelerated, and the market will be expected in the futu.
It has become a new growth point of the national econo.
At the same time, a large number of enterprises will usher in more opportunities under this backgrou.
However, the scope of the big health industry is broad, including nutritional health food, medical health equipment, leisure health care services, e.
Industry insiders believe that if companies can break the single product model and provide healthy life solutions, they may create greater business opportuniti.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
